-
1 Comment
Vital KSK Holdings, Inc is currently in a long term downtrend where the price is trading 9.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
Vital KSK Holdings, Inc's total revenue sank by 3.5% to $142B since the same quarter in the previous year.
Its net income has dropped by 104.7% to $-103M since the same quarter in the previous year.
Based on the above factors, Vital KSK Holdings, Inc gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Distribution |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3778280002 |
| Market Cap | 63B |
|---|---|
| PE Ratio | 8.61 |
| Target Price | None |
| Dividend Yield | 3.5% |
| Beta | 0.09 |
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. It operates through Pharmaceutical Wholesale Business; Pharmacy Business; Veterinary Drug Wholesale Business; and Other Businesses. The company is involved in the nursing care; agrochemical wholesale; and sale of pharmaceuticals, poisonous or deleterious substances, narcotics, quasi-drugs, vaccines, paints, pigments, dyes, medical equipment, sanitary materials, hygiene goods, nursing care products, and beverages. It also engages in the medical and pharmacy consulting business; general freight vehicle transportation; and insurance agency, real estate management, and parking lot operation. Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3151.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
